Н. У. Закиров

13 ta ish

Tashkent Pediatric Medical Institute

1. Interrelation between the rs2200733 polymorphism of the ATFB5 gene and atrial fibrillation in Uzbek patients

   Guzal Abdullaeva, А. А. Абдуллаев, Amayak Kevorkov +3

   MaqolaOAOchiq kirishCardiac electrophysiology and arrhythmiasTurk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology20211 iqtibos

   ABIABI:AkademIndex/2021.article.001551

2. [The cardioprotective action of 18-dehydroglycyrrhetic acid in experimental myocardial damage].

   Н. У. Закиров, M I Aĭzimov, Anvar Kurmukov

   MaqolaPharmacological Effects of Natural CompoundsPubMed19990 iqtibos

   ABIABI:AkademIndex/1999.article.000097

3. POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY

   R. D. Kurbanov, Н. У. Закиров, Ш. К. Азизов +1

   MaqolaOAOchiq kirish20120 iqtibos

   ABIABI:AkademIndex/2012.article.000581

4. Features of Heart Rate Variability and Early Postinfarction Remodeling Process in Patients with Recurrent Myocardial Infarction

   Corina Şerban, Р. Д. Курбанов, Н. У. Закиров +1

   MaqolaOAOchiq kirishHeart Rate Variability and Autonomic ControlDOAJ (DOAJ: Directory of Open Access Journals)20130 iqtibos

   ABIABI:AkademIndex/2013.article.000608

5. Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin

   R. D. Kurbanov, Н. У. Закиров, Oybek Salaev

   MaqolaOAOchiq kirishCardiac electrophysiology and arrhythmiasInternational Journal of Biomedicine20190 iqtibos

   ABIABI:AkademIndex/2019.article.000830

6. ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO

   R. D. Kurbanov, Г. Ж. Абдуллаева, T. Z. Ganiev +2

   MaqolaOAOchiq kirish20200 iqtibos

   ABIABI:AkademIndex/2020.article.008480

7. Comparative effectiveness of propafenone and aksaritmin for conversion of paroxysmal atrial fibrillation

   Husniddin Kuchkarov, Н. У. Закиров, R. D. Kurbanov +1

   MaqolaPlant-based Medicinal ResearchEP Europace20220 iqtibos

   ABIABI:AkademIndex/2022.article.005131

8. Comparative effectiveness of propafenone and aksaritmin for conversion of paroxysmal atrial fibrillation

   Husniddin Kuchkarov, Н. У. Закиров, Sh.K.Azizov +2

   MaqolaHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

   ABIABI:AkademIndex/2022.article.005403

9. Comparative Effectiveness of Aksaritmin and Propafenone in the Prevention of Atrial Fibrillation

   Husniddin Kuchkarov, Н. У. Закиров, R. D. Kurbanov

   MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesInternational Journal of Biomedicine20230 iqtibos

   ABIABI:AkademIndex/2023.article.008166

10. Blood lipid profile and ECG signs of left ventricle hypertrophy in patients with hystory of myocardial infarction

    E. Tursunov, Amayak Kevorkov, Н. У. Закиров +1

    MaqolaOAOchiq kirishCardiovascular Disease and AdiposityAtherosclerosis20230 iqtibos

    ABIABI:AkademIndex/2023.article.010115

11. Blood lipid profile and signal averaged ECG parameters in patients with hystory of myocardial infarction

    E. Tursunov, Amayak Kevorkov, Н. У. Закиров +1

    MaqolaOAOchiq kirishCardiovascular Disease and AdiposityAtherosclerosis20230 iqtibos

    ABIABI:AkademIndex/2023.article.010125

12. Dynamics of Non-Invasive Risk Factors of Sudden Cardiac Death after Myocardial Revascularization

    Ergashali Tursunov, Amayak Kevorkov, R. D. Kurbanov +2

    MaqolaOAOchiq kirishHeart Rate Variability and Autonomic ControlInternational Journal of Biomedicine20230 iqtibos

    ABIABI:AkademIndex/2023.article.010352

13. Preliminary results of studying the prevalence of atrial fibrillation and the adequacy of prevention of thromboembolic complications

    Н. У. Закиров, R D Qurbanov, D Irisov +3

    MaqolaOAOchiq kirishHealthcare Systems and Public HealthEuropean Heart Journal20230 iqtibos

    ABIABI:AkademIndex/2023.article.011552